Chronic kidney disease as a predictor of coronary lesion morphology

Angiology

Volumn 61, Issue 4, 2010, Pages 344-349

  Kilickesmez, Kadriye Orta ^a   Abaci, Okay ^a   Okcun, Baris ^a   Kocas, Cuneyt ^a   Baskurt, Murat ^a   Arat, Alev ^a   Ersanli, Murat ^a   Gurmen, Tevfik ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Chronic kidney disease; Coronary angiography; Coronary artery disease

Indexed keywords

CREATININE;

ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTERY LESION; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIALYSIS; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; RISK FACTOR; SMOKING;

AGED; CASE-CONTROL STUDIES; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 77952679386     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319709351875     Document Type: Article

References (40)

1. Collins AJ, Foley RN, Herzog C., et al. United States Renal Data System 2008 Annual Data Report Abstract. Am J Kidney Dis. 2009; 53 (1 suppl). vi-vii, S8-S374.
2. Go AS, Chertow GM, Fan D., McCulloch CE, Hsu CY Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351 (13). 1296-1305.
3. Flack JM, Neaton JD, Daniels B., Esunge P. Ethnicity and renal disease: lessons from the Multiple Risk Factor Intervention Trial and the Treatment of Mild Hypertension Study. Am J Kidney Dis. 1993; 21 (4 suppl 1). 31-40.
4. Ix JH, Mercado N., Shlipak MG, et al. Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS). Am Heart J. 2005; 149 (3). 512-519.
5. Blackman DJ, Pinto R., Ross JR, et al. Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention. Am Heart J. 2006; 151 (1). 146-152.
6. Koganei H., Kasanuki H., Ogawa H., Tsurumi Y. Association of glomerular filtration rate with unsuccessful primary percutaneous coronary intervention and subsequent mortality in patients with acute myocardial infarction: from the HIJAMI registry. Circ J. 2008; 72 (2). 179-185.
7. Cooper WA, O'Brien SM, Thourani VH, et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation. 2006; 113 (8). 1063-1070.
8. Guiteras-Val P., Varas-Lorenzo C., Garcia-Picart J., Martí- Claramunt V., Augé-Sanpera JM Clinical and sequential angiographic follow-up six months and 10 years after successful percutaneous transluminal coronary angioplasty. Am J Cardiol. 1999; 83 (6). 868-874.
9. Gruberg L., Dangas G., Mehran R., et al. Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure. Catheter Cardiovasc Interv. 2002; 55 (1). 66-72.
10. Best PJ, Lennon R., Ting HH, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol. 2002; 39 (7). 1113-1119.
11. Ryan TJ, Bauman WB, Kennedy JW, et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). Circulation. 1993; 88 (6). 2987-3007.
12. Kastrati A., Schãmig A., Elezi S., et al. Prognostic value of the modified American College of Cardiology/American heart association stenosis morphology classification for long-term angiographic and clinical outcome after coronary stent placement. Circulation. 1999; 100 (12). 1285-1290.
13. Ellis SG, Vandormael MG, Cowley MJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation. 1990; 82 (4). 1193-1202.
14. Austen WG, Edwards JE, Frye RL, et al. A reporting system on patients evaluated for coronary artery disease. Report ofbthe Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation. 1975; 51 (4 suppl). 5-40.
15. Serruys PW, Unger F., van Hout BA, et al. The ARTS study (Arterial Revascularization Therapies Study). Semin Interv Cardiol. 1999; 4 (4). 209-219.
16. Walser M. Assessing renal function from creatinine measurements in adults with chronic renal failure. Am J Kidney Dis. 1998; 32 (1). 23-31.
17. Levey AS, Bosch JP, Lewis JB, Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130 (6). 461-470.
18. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39 (2 suppl 1). S1-S266.
19. Baigent C., Burbury K., Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet. 2000; 356 (9224). 147-152.
20. Reddan DN, Szczech LA, Tuttle RH, et al. Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. J Am Soc Nephrol. 2003; 14 (9). 2373-2380.
21. McCullough PA Why is chronic kidney disease the "spoiler" for cardiovascular outcomes? J Am Coll Cardiol. 2003; 41 (5). 725-728.
22. Schrier RW Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol. 2006; 47 (1). 1-8.
23. Sarnak MJ, Levey AS Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis. 200; 35 (4 suppl 1). S117-S131.
24. Kennedy R., Case C., Fathi R., Johnson D., Isbel N., Marwick TH Does renal failure cause an atherosclerotic milieu in patients with end-stage renal disease? Am J Med. 2001; 110 (3). 198-204.
25. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000; 342 (12). 836-843. (Pubitemid 30165206) (Pubitemid 30165206)
26. Reddan DN, Szczech L., Bhapkar MV, et al. Renal function, concomitant medication use and outcomes following acute coronary syndromes. Nephrol Dial Transplant. 2005; 20 (10). 2105-2112.
27. McCullough PA, Sandberg KR, Borzak S., Hudson MP, Garg M., Manley HJ Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease. Am Heart J. 2002; 144 (2). 226-232.
28. Zoccali C., Mallamaci F., Parlongo S., et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation. 2002; 105 (11). 1354-1359. (Pubitemid 34260428) (Pubitemid 34260428)
29. Shepherd J., Kastelein JJ, Bittner V., et al., and the TNT (Treating to New Targets) Investigators. Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study. J Am Coll Cardiol. 2008; 51 (15). 1448-1554.
30. Athyros VG, Mikhailidis DP, Papageorgiou AA, et al. The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study. J Clin Pathol. 2004; 57 (7). 728-734.
31. Tonelli M., Isles C., Craven T., et al. Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease. Circulation. 2005; 112 (2). 171-178.
32. Blackman DJ, Pinto R., Ross JR, et al. Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention. Am Heart J. 2006; 151 (1). 146-152.
33. Koganei H., Kasanuki H., Ogawa H., Tsurumi Y. Association of glomerular filtration rate with unsuccessful primary percutaneous coronary intervention and subsequent mortality in patients with acute myocardial infarction: from the HIJAMI registry. Circ J. 2008; 72 (2). 179-185.
34. Hillis GS, Croal BL, Buchan KG, et al. Renal function and outcome from coronary artery bypass grafting: impact on mortality after a 2.3-year follow-up Circulation. 2006; 113 (8). 1056-1062.
35. Lemos PA, Arampatzis CA, Hoye A., et al. Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents. Am J Cardiol. 2005; 95 (2). 167-172.
36. Yamaguchi J., Kasanuki H., Ishii Y., et al. Prognostic significance of serum creatinine concentration for in-hospital mortality in patients with acute myocardial infarction who underwent successful primary percutaneous coronary intervention (from the Heart Institute of Japan Acute Myocardial Infarction [HIJAMI] Registry). Am J Cardiol. 2004; 93 (12). 1526-1528.
37. Naidu SS, Selzer F., Jacobs A., et al. Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention. Am J Cardiol. 2003; 92 (10). 1160-1164.
38. Russo D., Palmiero G., De Blasio AP, Balletta MM, Andreucci VE Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis. 2004; 44 (6). 1024-1030.
39. Aoki J., Ong AT, Hoye A., et al. Five year clinical effect of coronary stenting and coronary artery bypass grafting in renal insufficient patients with multivessel coronary artery disease: insights from ARTS trial. Eur Heart J. 2005; 26 (15). 1488-1493.
40. Khattab AA, Hamm CW, Senges J., et al. Prognostic value of the modified American College of Cardiology/American Heart Association lesion morphology classification for clinical outcome after sirolimus-eluting stent placement (results of the prospective multicenter German Cypher Registry). Am J Cardiol. 2008; 101 (4). 477-482.